DS MED LLC - 17 May 2022 Form 4 Insider Report for Longeveron Inc. (LGVN)

Reporting relationship: 10%+ Owner
Issuer ticker: LGVN
Reported as of: 17 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 May 2022, 18:00:41 UTC
Prior SEC filing: 15 Apr 2022
Source filing: View source filing
Reporting owner signature: /s/ Paul T. Lehr, attorney-in-fact

Key filing fact

DS MED LLC filed Form 4 for Longeveron Inc. (LGVN) on 19 May 2022.

Key facts

This page summarizes DS MED LLC's Form 4 filing for Longeveron Inc. (LGVN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 May 2022, 18:00.

Change

Previous filing in this sequence was filed on 15 Apr 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LGVN transaction

Common Stock

Other

Transaction value: $0
Shares: -7,024,208
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 17 May 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

DS MED LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

Footnote F2

Shares distributed on a pro rated basis to members of DS Med, LLC, for no consideration.